Concepedia

Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations

James D. Lewis, Oren Abramson, M. Pascua, Liyan Liu, Laura Asakura, Fernando Velayos, Susan Hutfless, James E. Alison, Lisa J. Herrinton

Clinical Gastroenterology and Hepatology · 2009 · 64 citations · 14 references

DOI

Concepts

References

14

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

Marla C. Dubinsky, Stéphanie Lamothe, Hui Ying Yang et al. · Gastroenterology · 2000 · 1K citations · Full text

, , +16

6-Mercaptopurine in the Management of Inflammatory Bowel Disease: Short- and Long-Term Toxicity

Daniel H. Present, Stephen J. Meltzer, Michael P. Krumholz et al. · Annals of Internal Medicine · 1989 · 737 citations

, , +11

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

Jean‐Frédéric Colombel, Nicolas Ferrari, Hervé Debuysère et al. · Gastroenterology · 2000 · 615 citations · Full text

, , +17

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

Sandro Ardizzone · Gut · 2005 · 508 citations · Full text

, , +16

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

A. B. Hawthorne, Richard F. Logan, Chris J. Hawkey et al. · BMJ · 1992 · 458 citations · Full text

, , +14